6 results

• GalaFLEX Breast Mesh Problems Were Highlighted in Warnings Issued by Former Becton Dickinson Medical Director

  November 14, 2025

  Russell Maas

  Former Becton Dickinson safety officer Dr. Hooman Noorchashm warns that the company’s GalaFLEX mesh is being used off-label in breast reconstruction without FDA approval, as lawsuits investigate whether the manufacturer failed to warn about its potential risks.

• Breast Mesh Reconstruction Surgery Gaining Popularity Despite Safety Concerns, Lawsuits

  November 10, 2025

  Irvin Jackson

  The potential for breast mesh reconstruction lawsuits is growing, as manufacturers continue to market the devices without FDA approval despite increasing evidence of serious complications.

• Internal Bra Mesh Failure Stories Highlight Risk of Pain, Infections and Other Problems

  November 6, 2025

  Russell Maas

  Women are sharing alarming reports of pain, infections, and reconstruction failures caused by internal bra mesh implants like GalaFLEX, as the FDA confirms these devices were never approved for breast surgery and lawsuits now allege manufacturers failed to warn about the risks.

• Internal Bra Side Effects Raise Questions About Manufacturers’ Knowledge of Mesh Failures

  October 27, 2025

  Russell Maas

  Breast mesh products marketed as “internal bras” for lift and augmentation surgeries are now under investigation amid reports of painful complications, and questions over manufacturers’ prior knowledge of mesh-related risks.

• Breast Mesh Problems Prompted FDA Warnings Over Off-Label Use

  October 15, 2025

  Russell Maas

  Federal regulators warned years ago that mesh implants were never approved for use in breast surgery, yet manufacturers continued marketing them as internal bra devices for reconstruction and cosmetic augmentation.

• Breast Mesh Lawsuits May Follow Recent Studies Highlighting Internal Bra Complications

  October 9, 2025

  Russell Maas

  Breast mesh implants promoted as internal bras are now under scrutiny, following studies and FDA warnings linking the devices to infections, implant loss, and surgical failure. Lawsuits are being investigated for women who suffered complications after reconstruction or augmentation procedures involving products like GalaFLEX, Phasix, Strattice, and AlloDerm.